In 2020, many clinical trials were brought to a halt by the COVID-19 pandemic. As communities across the globe work to flatten the curve and look toward post-pandemic life, life sciences organizations will be jumping back into their clinical trials with increased veracity. Hear how other life sciences and healthcare can leverage low-code automation in the management of treatment protocol and amendments that need to be updated and maintained in a rapidly changing environment. Take a look at how organizations can stand up their studies again quickly, while maintaining patient safety and adhering to regulatory requirements.
Speaker
Evi Cohen, Appian